Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
about
Bilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological InnovationsMild cognitive impairment in Parkinson's disease.The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic ReviewParkinson's Disease and Cognitive ImpairmentMismatch negativity latency as a biomarker of amnestic mild cognitive impairment in chinese rural elders.Detection of cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome using mismatch negativity.Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of PennsyPeople with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceMini mental Parkinson test: standardization and normative data on an Italian sample.Normative data for the Montreal Cognitive Assessment in an Italian population sample.BrainCheck - a very brief tool to detect incipient cognitive decline: optimized case-finding combining patient- and informant-based data.Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia.Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults.Using Cognitive Screening Tests in AudiologyDopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseRandomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes.Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease.A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseParkinson's disease: the quintessential neuropsychiatric disorderUse of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.History of smoking and olfaction in Parkinson's disease.Cognitive impairment in CKD: no longer an occult burdenA recommended scale for cognitive screening in clinical trials of Parkinson's disease.Veterans Affairs Saint Louis University Mental Status examination compared with the Montreal Cognitive Assessment and the Short Test of Mental Status.Cognitive screening in brain tumors: short but sensitive enough?APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.Predictors of cognitive impairment in an early stage Parkinson's disease cohortV-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial.Short and valid assessment of apraxia in Parkinson's disease.Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.Neuroimaging signatures and cognitive correlates of the montreal cognitive assessment screen in a nonclinical elderly samplePrediction of driving ability with neuropsychological tests: demographic adjustments diminish accuracy.Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtableUse of the MoCA in Detecting Early Alzheimer's Disease in a Spanish-Speaking Population with Varied Levels of Education.MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.Cognitive effects of calligraphy therapy for older people: a randomized controlled trial in Hong KongScreening Mild and Major Neurocognitive Disorders in Parkinson's Disease.Circadian Levels of Serum Melatonin and Cortisol in relation to Changes in Mood, Sleep, and Neurocognitive Performance, Spanning a Year of Residence in Antarctica.
P2860
Q26770439-E1EE5F2F-5701-4925-9A34-148F7E574FAFQ27021220-9E466F73-D0DB-405A-A9AC-0461FFF4B30EQ28070324-8D86DF86-CDF7-4B67-87BF-20A9EBA4BBE9Q30239814-EA3BDC3F-35F3-4AD8-84A8-5D071F70537FQ30415954-8F69E2FF-F682-4A45-9A7F-6D129CC0F025Q30419392-EBEC2FA3-C607-4031-89BD-52E0964926CAQ30538175-1C6529EF-FBDC-48A4-A00E-399E2FBABC73Q30586896-2E87251E-D71E-4985-AB41-DAC4ABDDF898Q30597329-9999719F-6395-4B93-B26C-3E9462F6E777Q30868439-020AD6F6-0095-4E73-A2A9-99CB33D65240Q30871684-CEA8949B-31A2-41D7-9BC1-235E96A0CD8DQ31047682-B82A24AB-194D-494F-AAEA-52E0EDBEDDD9Q31090318-CD5C9943-886D-4C56-867E-626E94369AB2Q33588634-3FADF6E2-559E-4189-9B88-885986BB64D4Q33602588-1FF43521-DCD1-4A6A-BB34-34B9358C1E08Q33647691-00BAF89C-6601-4328-8781-DC09F23B5FD9Q33736797-4019BB4E-D115-498C-B90D-36B48C0802AFQ33744548-5D44DC20-FFE1-403C-9E39-B05FF9ED9A29Q33788172-D9D48CB1-4FF4-4291-B48F-95310EBDC55EQ33917094-19B4E338-15D4-4935-A2D4-D07AD839342DQ33925218-9C308D18-7306-411B-8EC6-44484A3F70A4Q33934900-8D3C76A4-E97F-4FE1-ACAE-D26B800DDE48Q34145685-8DA271A7-A6E3-45D6-BEDB-AF95E84A2B56Q34300160-A4F72478-FAE9-4320-9F07-37DD3FD2D6CBQ34424035-D01CD3F6-88A0-49DA-ACA0-BE09CEEC08B5Q34468924-17578612-EE43-4DC5-9783-B1C782B8EDD6Q34490496-1E1C3F85-BAAC-4CB9-8A22-835E7974DAC1Q34531319-2D29802C-678B-4F61-BB67-F6B80BBC399AQ34578767-BBE387B9-07E7-4C95-AD71-722AD7ED922DQ35039248-54D0B51E-BB09-46D2-B007-6DABEE446F51Q35124579-8F6165A9-36CF-4D9F-94B3-6F8353A1A7DDQ35126092-3CEAB02C-75FE-49AE-8D03-15F7637AF61EQ35154472-EEDB5284-4E6B-46B8-B2D3-B2F561C1E5C8Q35211543-D7937501-A4EB-4A71-9A60-C02F00BEAADEQ35211545-98CFA4F4-F384-4AEC-B0F9-FB1DA936E8A3Q35225335-E5B46172-CDBA-4C61-8CDB-0FF1436982A0Q35234522-22C472B6-9D7F-46FB-A10D-9EFD2811A017Q35539281-F1153A18-BDC3-4A8C-838D-A2645DCE8FDBQ35674661-E4FB09D1-E734-4081-804C-DE8835BD028EQ35693263-D03D66C1-9526-4BD3-844A-2C1CFA00D813
P2860
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@ast
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@en
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
@nl
type
label
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@ast
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@en
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
@nl
prefLabel
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@ast
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@en
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
@nl
P2093
P2860
P1433
P1476
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
@en
P2093
A D Siderowf
D Weintraub
P2860
P304
P356
10.1212/WNL.0B013E3181C34B47
P407
P577
2009-11-01T00:00:00Z